Loading…
Medi Caps (BSE 523144)₹25.42+5.00%Pharmaceuticals
Medi Caps is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −2.6% against a peer median of −5.8%, and latest-quarter sales growth of 3.7% against a peer median of 1.0%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vista Pharmaceuticals | 41 | — | −30.0 | −29.5 | 0.27 | 0.0 | 5 | −12 | −100.0 | — | vs BSE 523144 |
| Bharat Immunological & Biological Corporation | 38 | — | −8.9 | −17.7 | 0.94 | 0.0 | 45 | −17 | −100.0 | — | vs BSE 523144 |
| Rajnish Wellness | 38 | — | −9.0 | −6.7 | 0.00 | 0.0 | 143 | −6 | 1,667.0 | — | vs BSE 523144 |
| Sandu Pharmaceuticals | 36 | 19.7 | 6.5 | 4.1 | 0.01 | 2.2 | 70 | 2 | 19.9 | −90.6 | vs BSE 523144 |
| Gujarat Terce Laboratories | 35 | 16.4 | 39.3 | 30.2 | 0.13 | 0.0 | 47 | 2 | −17.1 | — | vs BSE 523144 |
| Roopa Industries | 35 | 549.5 | 15.0 | 23.2 | 1.75 | 0.0 | 128 | 0 | 1.0 | −434.9 | vs BSE 523144 |
| Medi Caps | 32 | — | −2.6 | −2.6 | 0.00 | 0.0 | 12 | −3 | 3.7 | — | — |
| Medicamen Organics | 32 | — | −10.6 | −13.8 | 0.50 | 0.0 | 23 | −4 | −77.9 | −338.4 | vs BSE 523144 |
| Goldline Pharmaceutical | 29 | 5.0 | 30.6 | 39.4 | 0.88 | 0.0 | 31 | 4 | — | — | vs BSE 523144 |
| Medi Caps | 26 | — | −9.3 | −9.2 | 0.00 | 0.0 | 12 | −3 | 3.7 | — | vs BSE 523144 |
| Bacil Pharma | 24 | 15.6 | — | — | 0.00 | 0.0 | 0 | 2 | — | — | vs BSE 523144 |
| Peer median | 35 | 16.4 | −5.8 | −4.7 | 0.13 | 0.0 | 31 | −3 | 1.0 | −338.4 |
Listed companies closest to Medi Caps in Pharmaceuticals include Vista Pharmaceuticals, Bharat Immunological & Biological Corporation, Rajnish Wellness, Sandu Pharmaceuticals, Gujarat Terce Laboratories, Roopa Industries, Medicamen Organics, Goldline Pharmaceutical.
Vista Pharmaceuticals, with a market cap of ₹41.21 Cr.
Medi Caps' return on capital employed is −2.6%, above the peer median of −5.8%.